4//SEC Filing
Witherspoon Charles 4
Accession 0001127602-24-026141
CIK 0000105770other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 12:05 PM ET
Size
9.5 KB
Accession
0001127602-24-026141
Insider Transaction Report
Form 4
Witherspoon Charles
VP & Treasurer
Transactions
- Sale
Common Stock
2024-10-29$310.40/sh−478$148,371→ 1,478.141 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-10-29−478→ 0 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Stock Options (Right to Buy) (478 underlying) - Exercise/Conversion
Common Stock
2024-10-29$173.22/sh+478$82,799→ 1,956.141 total - Sale
Common Stock
2024-10-29$310.40/sh−225$69,840→ 1,253.141 total
Footnotes (1)
- [F1]This award vested in four equal annual installments beginning on February 18, 2021.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001731739
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 12:05 PM ET
- Size
- 9.5 KB